SCHEMBL7215644

SCHEMBL7215644

O=C(O)c1ccc(-c2coc(-c3ccccc3)n2)cc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.58
RAB9A P51151 3/20 0.58
ENPP3 O14638 2/20 0.57
ENPP1 P22413 2/20 0.57
SMO Q99835 2/20 0.56
ALDH1A1 P00352 2/20 0.51
KDM4E B2RXH2 2/20 0.51
HSD17B1 P14061 1/20 0.51
HSD17B2 P37059 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
HDAC1 Q13547 2/20 0.50
HDAC8 Q9BY41 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
LDHA P00338 1/20 0.47
NR1H4 Q96RI1 1/20 0.47
CTRC Q99895 1/20 0.45
KMT2A Q03164 1/20 0.44
CHEK1 O14757 1/20 0.44
EGFR P00533 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7215456 1.00 NPC1 (0.58) NPC1RAB9AENPP3ENPP1SMO
SCHEMBL16199783 0.89 HSD17B1 (0.57) NPC1RAB9AENPP3ENPP1SMO
SCHEMBL12170957 0.88 SMN1; SMN2 (0.52) NPC1RAB9AENPP3ENPP1SMO
SCHEMBL7217120 0.88 NPC1 (0.54) NPC1RAB9AENPP3ENPP1SMO
SCHEMBL11524375 0.88 SMO (0.57) NPC1RAB9AENPP3ENPP1SMO
SCHEMBL7221671 0.88 NPC1 (0.54) NPC1RAB9AENPP3ENPP1SMO
SCHEMBL2944536 0.86 ENPP3 (0.53) NPC1RAB9AENPP3ENPP1SMO
SCHEMBL3271684 0.86 ENPP3 (0.72) NPC1RAB9AENPP3ENPP1SMO
SCHEMBL11566150 0.86 ENPP3 (0.72) NPC1RAB9AENPP3ENPP1SMO
SCHEMBL12170985 0.85 HSD17B1 (0.57) NPC1RAB9AENPP3ENPP1SMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6545009-B1 Imidazole, oxazole and thiazole derivatives for regulation of peroxisome proliferator-activated receptor function; improving insulin resistance, treating impaired glucose tolerance and obesity, enhancing insulin sensitivity, etc. TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-04-08 US disclosed
EP-1092711-A1 RETINOID-ASSOCIATED RECEPTOR REGULATORS Takeda Chemical Industries, Ltd. (JP) 2001-04-18 EP disclosed